469 related articles for article (PubMed ID: 19084549)
1. Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells.
Lambert CB; Spire C; Claude N; Guillouzo A
Toxicol Appl Pharmacol; 2009 Feb; 234(3):345-60. PubMed ID: 19084549
[TBL] [Abstract][Full Text] [Related]
2. Reproducible chemical-induced changes in gene expression profiles in human hepatoma HepaRG cells under various experimental conditions.
Lambert CB; Spire C; Renaud MP; Claude N; Guillouzo A
Toxicol In Vitro; 2009 Apr; 23(3):466-75. PubMed ID: 19159669
[TBL] [Abstract][Full Text] [Related]
3. Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells.
Aninat C; Piton A; Glaise D; Le Charpentier T; Langouët S; Morel F; Guguen-Guillouzo C; Guillouzo A
Drug Metab Dispos; 2006 Jan; 34(1):75-83. PubMed ID: 16204462
[TBL] [Abstract][Full Text] [Related]
4. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics.
Guillouzo A; Corlu A; Aninat C; Glaise D; Morel F; Guguen-Guillouzo C
Chem Biol Interact; 2007 May; 168(1):66-73. PubMed ID: 17241619
[TBL] [Abstract][Full Text] [Related]
5. Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells.
Anthérieu S; Chesné C; Li R; Camus S; Lahoz A; Picazo L; Turpeinen M; Tolonen A; Uusitalo J; Guguen-Guillouzo C; Guillouzo A
Drug Metab Dispos; 2010 Mar; 38(3):516-25. PubMed ID: 20019244
[TBL] [Abstract][Full Text] [Related]
6. DHA down-regulates phenobarbital-induced cytochrome P450 2B1 gene expression in rat primary hepatocytes by attenuating CAR translocation.
Li CC; Lii CK; Liu KL; Yang JJ; Chen HW
Toxicol Appl Pharmacol; 2007 Dec; 225(3):329-36. PubMed ID: 17904175
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte iron loading capacity is associated with differentiation and repression of motility in the HepaRG cell line.
Troadec MB; Glaise D; Lamirault G; Le Cunff M; Guérin E; Le Meur N; Détivaud L; Zindy P; Leroyer P; Guisle I; Duval H; Gripon P; Théret N; Boudjema K; Guguen-Guillouzo C; Brissot P; Léger JJ; Loréal O
Genomics; 2006 Jan; 87(1):93-103. PubMed ID: 16325370
[TBL] [Abstract][Full Text] [Related]
8. Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line.
Le Vee M; Jigorel E; Glaise D; Gripon P; Guguen-Guillouzo C; Fardel O
Eur J Pharm Sci; 2006 May; 28(1-2):109-17. PubMed ID: 16488578
[TBL] [Abstract][Full Text] [Related]
9. Temporal kinetics and concentration-response relationships for induction of CYP1A, CYP2B, and CYP3A in primary cultures of beagle dog hepatocytes.
Graham RA; Tyler LO; Krol WL; Silver IS; Webster LO; Clark P; Chen L; Banks T; LeCluyse EL
J Biochem Mol Toxicol; 2006; 20(2):69-78. PubMed ID: 16615094
[TBL] [Abstract][Full Text] [Related]
10. Targeted salmon gene array (SalArray): a toxicogenomic tool for gene expression profiling of interactions between estrogen and aryl hydrocarbon receptor signalling pathways.
Mortensen AS; Arukwe A
Chem Res Toxicol; 2007 Mar; 20(3):474-88. PubMed ID: 17291011
[TBL] [Abstract][Full Text] [Related]
11. D-Serine exposure resulted in gene expression changes indicative of activation of fibrogenic pathways and down-regulation of energy metabolism and oxidative stress response.
Soto A; DelRaso NJ; Schlager JJ; Chan VT
Toxicology; 2008 Jan; 243(1-2):177-92. PubMed ID: 18061331
[TBL] [Abstract][Full Text] [Related]
12. Time- and concentration-dependent changes in gene expression induced by benzo(a)pyrene in two human cell lines, MCF-7 and HepG2.
Hockley SL; Arlt VM; Brewer D; Giddings I; Phillips DH
BMC Genomics; 2006 Oct; 7():260. PubMed ID: 17042939
[TBL] [Abstract][Full Text] [Related]
13. Measurement of cytochrome P450 gene induction in human hepatocytes using quantitative real-time reverse transcriptase-polymerase chain reaction.
Bowen WP; Carey JE; Miah A; McMurray HF; Munday PW; James RS; Coleman RA; Brown AM
Drug Metab Dispos; 2000 Jul; 28(7):781-8. PubMed ID: 10859152
[TBL] [Abstract][Full Text] [Related]
14. Identification of early target genes of aflatoxin B1 in human hepatocytes, inter-individual variability and comparison with other genotoxic compounds.
Josse R; Dumont J; Fautrel A; Robin MA; Guillouzo A
Toxicol Appl Pharmacol; 2012 Jan; 258(2):176-87. PubMed ID: 22100608
[TBL] [Abstract][Full Text] [Related]
15. Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties.
Wilkening S; Stahl F; Bader A
Drug Metab Dispos; 2003 Aug; 31(8):1035-42. PubMed ID: 12867492
[TBL] [Abstract][Full Text] [Related]
16. Expression profiling of human hepatoma cells reveals global repression of genes involved in cell proliferation, growth, and apoptosis upon infection with parvovirus H-1.
Li J; Werner E; Hergenhahn M; Poirey R; Luo Z; Rommelaere J; Jauniaux JC
J Virol; 2005 Feb; 79(4):2274-86. PubMed ID: 15681429
[TBL] [Abstract][Full Text] [Related]
17. Altered gene expression in human hepatoma HepG2 cells exposed to low-level 2,4-dichlorophenoxyacetic acid and potassium nitrate.
Bharadwaj L; Dhami K; Schneberger D; Stevens M; Renaud C; Ali A
Toxicol In Vitro; 2005 Aug; 19(5):603-19. PubMed ID: 15878651
[TBL] [Abstract][Full Text] [Related]
18. Patterns of expression of cytochrome P450 genes in progression of hepatitis C virus-associated hepatocellular carcinoma.
Tsunedomi R; Iizuka N; Hamamoto Y; Uchimura S; Miyamoto T; Tamesa T; Okada T; Takemoto N; Takashima M; Sakamoto K; Hamada K; Yamada-Okabe H; Oka M
Int J Oncol; 2005 Sep; 27(3):661-7. PubMed ID: 16077914
[TBL] [Abstract][Full Text] [Related]
19. The aryl hydrocarbon receptor agonist 3,3',4,4',5-pentachlorobiphenyl induces distinct patterns of gene expression between hepatoma and glioma cells: chromatin remodeling as a mechanism for selective effects.
Maier MS; Legare ME; Hanneman WH
Neurotoxicology; 2007 May; 28(3):594-612. PubMed ID: 17316808
[TBL] [Abstract][Full Text] [Related]
20. Gene expressions associated with chemosensitivity in human hepatoma cells.
Hoshida Y; Moriyama M; Otsuka M; Kato N; Taniguchi H; Shiratori Y; Seki N; Omata M
Hepatogastroenterology; 2007 Mar; 54(74):489-92. PubMed ID: 17523305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
